Pharmaceutical Research Associates Group B.V. — Clinical Trial Site

113 Registered trials

21 Currently recruiting

Organisation

Pharmaceutical Research Associates Group B.V.

Location

Groningen, Netherlands

Identifier

ORG-100006268

Address

Van Swietenlaan 6, 9728 NZ, Netherlands

Departments

#001_00270428: Program Management
Clinical research ICON
Clinical Research Unit Groningen
Early Development Service
Early Clinical Services
Early Development
General
N/A
Phase 1 unit
Program Management
Program Management
Program Menagement

Clinical trials at this site (113)

Search interface

A phase I study of [68Ga]Ga-DWJ155 in patients with advanced breast and NSCLC cancers Pending

2024-517746-34-00 Advanced breast cancer and advanced NSCLC 1
A PHASE 1 STUDY WITH SINGLE ASCENDING DOSE, MULTIPLE ASCENDING DOSE AND FOOD EFFECT OF LMT503 IN HEALTHY SUBJECTS. Pending

2024-519180-17-00 Healthy volonteers 1
A study investigating the safety, absorption, and elimination of RO7795068, a new compound that may potentially be used in the treatment of … Pending

2024-519296-25-00 Healthy volunteers 3
Food effect and single- and multiple-ascending dose clinical trial of DF2755A in healthy participants Pending

2025-522935-32-00 interstitial cystitis/bladder pain syndrome 3
A PHASE 1, OPEN-LABEL STUDY TO ASSESS THE ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION, INCLUDING THE MASS BALANCE, OF A SINGLE ORAL … Pending

2025-524832-20-00 Healthy volunteers 3
A First-in-Human Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of MR-L45 in Healthy Adults Pending

2025-524899-40-00 Autosomal Dominant Polycystic Kidney Disease 1
Mass Balance and Absolute Oral Bioavailability of [14C]VH4524184 Pending

2026-525590-40-00 human immunodeficiency virus (HIV) 3
Thorough QT/QTc study with GLPG3667, placebo, and active comparator in healthy subjects Pending

2026-525788-42-00 Healthy volunteers 3
A Randomized Study in Healthy Participants to Identify the Optimal Subcutaneous Injection Strategy for COR-1167 Pending

2026-526096-31-00 Chronic Heart Failure 3
150 mg CIT-013 phase 1 trial Recruiting

2026-526153-34-00 Immune mediated inflammatory diseases 3 2026-05-26
A study to assess the safety, and blood levels of CTX-187 after single and repeated intravenous doses in healthy volunteers and patients wit… Recruiting

2026-525619-15-00 Bacterial Infection 1 2026-05-22
Multiple Dose Study of RO7795068 and its effect on Gastric Emptying, and on PK of Oral Contraceptives Recruiting

2025-524052-58-00 Healthy Overweight or Obese 3 2026-05-21
A study to investigate the safety, tolerability, pharmacokinetics, immunogenicity and pharmacodynamics of a single subcutaneous dose of GSK4… Recruiting

2025-525073-37-00 Autosomal Dominant Polycystic Kidney Disease 3 2026-05-12
A PHASE 1, OPEN-LABEL, SINGLE-DOSE MASS BALANCE AND METABOLITE PROFILING STUDY OF 14C-LABELED IZICOPAN (INF904) IN HEALTHY MALE PARTICIPANTS Recruiting

2026-525517-31-00 Not applicable, healthy volunteers 3 2026-05-04
Mass Balance Study of [14C] ABBV-932 in Healthy Male Volunteers Recruiting

2024-514454-75-00 Healthy Volunteers 3 2026-04-16
A trial comparing how the body absorbs and gets rid of petadeferitrin taken as two different forms in healthy people Recruiting

2025-525025-12-00 Iron overload from thalassemia, transfusion-dependent m 3 2026-04-10
A Phase I, open-label, non-randomized study to assess the absorption, distribution, metabolism and excretion (ADME) and pharmacokinetics of … Recruiting

2025-524172-29-00 Healthy volunteers 3 2026-03-18
A study to see how RO7763505 works and how safe it is when given to healthy people and people with stable heart disease Recruiting

2025-524693-42-00 Stable Coronary Artery Disease (CAD) 1 2026-03-09
A Phase I study to evaluate the Safety, Tolerability, and Pharmacokinetics of BAL2420 in Healthy Adult Subjects Recruiting

2025-523108-59-00 Severe infections caused by Gram-negative bacteria 1 2026-03-04
A single and multiple ascending dose study of topical ladarixin ophthalmic solution in healthy volunteers Recruiting

2025-524527-46-00 Ocular inflammatory conditions 1 2026-02-16
A research study to look at the distribution and effects of coramitug on amyloid deposits in heart tissue using PET/CT imaging in people wit… Recruiting

2024-519372-22-00 transthyretin amyloid amyloidosis cardiomyopathy (ATTR 3 2026-02-12
A Study Evaluating the Safety and Tolerability of a Novel Formulation of QRL-101 in Healthy Participants Recruiting

2025-524310-28-00 Epilepsy, amotrophic lateral sclerosis, neuropathy 3 2026-02-02
A Single-Center, Double-Blind, Randomized, Placebo Controlled Phase 1 Study to Investigate the Safety, Tolerability, Pharmacokinetics, and P… Recruiting

2025-523885-25-00 Healthy Volunteers 1 2026-01-21
A PHASE 1 TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PK, AND PD of AX-0810 IN HEALTHY PARTICIPANTS Recruiting

2025-521876-77-00 Cholestatic liver disease 1 2025-11-03